Primary malignant melanoma of the anus and rectum is a rare, highly lethal neoplasm. Mucosal melanomas account for approximately 1.2% of all melanomas, and anorectal melanomas account for fewer than 25% of all mucosal melanomas. 1 The 5-year survival rate for anorectal melanomas has been reported as less than 20%, compared with a reported mean 5-year survival for cutaneous melanomas of approximately 80%. 1 Owing to its rarity and histologic variability, misdiagnosis as lymphoma, carcinoma, or sarcoma is common. [2] [3] [4] Although the morphologic patterns of anorectal melanoma have been described, 5 the immunohistochemical staining of these lesions has been described in only a few case reports and small series. [6] [7] [8] [9] [10] [11] [12] [13] The majority of these reports demonstrate staining for S-100 protein and with HMB-45, but other common markers of melanoma (including MelanA and tyrosinase) have not been reported.
Primary malignant melanoma of the anus and rectum is a rare, highly lethal neoplasm. Mucosal melanomas account for approximately 1.2% of all melanomas, and anorectal melanomas account for fewer than 25% of all mucosal melanomas. 1 The 5-year survival rate for anorectal melanomas has been reported as less than 20%, compared with a reported mean 5-year survival for cutaneous melanomas of approximately 80%. 1 Owing to its rarity and histologic variability, misdiagnosis as lymphoma, carcinoma, or sarcoma is common. [2] [3] [4] Although the morphologic patterns of anorectal melanoma have been described, 5 the immunohistochemical staining of these lesions has been described in only a few case reports and small series. [6] [7] [8] [9] [10] [11] [12] [13] The majority of these reports demonstrate staining for S-100 protein and with HMB-45, but other common markers of melanoma (including MelanA and tyrosinase) have not been reported.
Numerous studies have investigated immunohistochemical markers of prognosis for cutaneous melanomas. [14] [15] [16] Several studies have shown that loss of c-kit expression is associated with metastasis and aggressive clinical behavior. [17] [18] [19] [20] Anorectal melanomas are considered uniformly aggressive lesions with early metastasis and a high mortality. We postulated that despite the differences in etiology between cutaneous and anorectal melanomas, loss of KIT might have a role in tumor development and prognosis. We reviewed the morphologic and immunohistochemical features of 17 anorectal melanomas.
Materials and Methods
The University of Virginia (Charlottesville) Department of Pathology files were reviewed, and 21 cases of anorectal melanoma, including referral and in-house material, were accessioned between October 1947 and July 2005. Of these, 17 cases had paraffin blocks or unstained slides available for review and immunohistochemical staining. Five patients were treated at the University of Virginia Medical Center, and an additional 12 cases were seen in consultation from multiple outside institutions. Clinical follow-up data, available for 13 cases, were obtained from primary physicians, contributing pathologists, and the medical records of the University of Virginia.
In cases with paraffin blocks available, 5-µm sections were cut and stained with H&E. In cases without paraffin blocks available, one previous slide was destained and restained with H&E. Tumor cells were classified as epithelioid, lymphoma-like, spindle cell, or pleomorphic. Pigmentation was graded as marked, moderate, focal, or absent. Melanocytic junctional or in situ change was recorded, as was the mitotic rate per high-power field (HPF).
The 
Results

Clinical Findings
The clinical data at initial diagnosis and follow-up for all 17 cases are given in ❚Table 1❚. For 5 patients, minimal or no staging and/or follow-up information was available. The mean age at presentation was 69.4 years (median, 67 years), and the male/female ratio was 1:1.1. The most common presentation was rectal bleeding (9 cases), followed by pain (5 cases), changes in bowel habits (3 cases), sensation of mass (3 cases), hemorrhoids (2 cases), and diarrhea (1 case). Two cases were discovered incidentally during screening colonoscopy. The mean length of follow-up was 25.6 months (median, 13 months), with 9 patients dead of tumor, 3 living with tumor, and 1 alive without tumor. Of the patients who died of disease during follow-up, the mean time to death from diagnosis was 32.3 months (median, 16 months).
Six patients had stage 1 disease at presentation, 6 had local lymph node metastases documented at the time of initial diagnosis (stage 2), and for 5, insufficient staging information was available. During the follow-up interval, metastases developed in 6 patients with initial stage 1 disease. Eight patients were treated with abdominoperineal resection (APR) and 5 with local excision. Five patients received adjunctive therapy, including chemotherapy, radiation therapy, and vaccine trial enrollment. In both patients with tumors discovered by screening colonoscopy, lymph node metastases developed (one at the time of diagnosis, one subsequently); they were alive with tumor at last follow-up after APR and adjunctive treatment. The mean survival overall was 25.6 months (median, 13 months), with no difference by stage at presentation or treatment (APR vs local excision) ❚Table 2❚. These survival data are similar to those seen in other case series of anorectal melanoma, which show a decrease in survival with increasing stage and no difference in survival related to therapy (APR vs local excision), although APR has better control of local recurrence. [21] [22] [23] [24] 
Gross Features
Of the cases with well-documented gross features ❚Table 3❚, the majority were present at the pectinate line (13/14) . One case was identified at the right lateral dentate line. Gross tumor size ranged from 1 to 6 cm, and 5 of 11 cases appeared pigmented on gross inspection. The majority of tumors had a polypoid appearance (8 cases), whereas 5 were ulcerated and 2 were fungating.
Histopathologic Findings
There was wide variation in tumor morphologic features between and within cases ❚Table 4❚. Four histologic cell types were observed: epithelioid, spindle cell, lymphoma-like, and pleomorphic. The majority of cases showed more than 1 cell type (13 cases); however, cases showing only 1 cell type included lymphoma-like, spindle cell, and pleomorphic morphologic features, which could be easily confused with a nonmelanocytic malignancy ❚Image 1❚. Only 5 of 17 cases showed significant pigmentation (2+ or greater), and 8 were amelanotic. Junctional change was present in 6 of 10 cases, which had nearby mucosal surface available for review ❚Image 2❚. The mitotic rate averaged 2.82 mitotic figures per high-power field (range, 0.5-5.5 per high-power field). mean tumor thickness was 10.2 mm (median, 9 mm); however, in 9 cases the tumor extended to the base of the biopsy and or resection. Depth of tumor invasion was classified as within the lamina propria (5 cases), involving the submucosa (6 cases), invading the internal sphincter muscle (2 cases), and invading the perirectal fat (4 cases).
Immunohistochemical Findings
The malignant cell population showed strong and diffuse staining for S-100 protein in all cases ❚Table 5❚. The majority of cases stained for MelanA and tyrosinase and with HMB-45, although there was greater variability in the strength and distribution ❚Image 3❚. Vimentin was used as a control for staining and was positive in all tumors but 1. In the single vimentin-negative case, the surrounding stroma and vasculature were positive. Staining for kit was present in 12 of 16 cases, the majority of which showed strong expression. Five of 6 spindle cell cases and 4 of 5 pleomorphic cell cases were positive for KIT. Pankeratin was absent in all cases.
Case 4 was unique in that it morphologically contained 2 distinct types, epithelioid and lymphoma-like, which stained strikingly differently on the same slide ❚Image 4❚. The epithelioid portion of the tumor was diffusely positive for S-100 protein and vimentin and negative for all other melanocytic markers, whereas the lymphoma-like tumor cells were diffusely positive with HMB-45 and for S-100 protein, tyrosinase, and vimentin and focally positive for MelanA. Staining for KIT was intermediate in distribution and weakly positive in the epithelioid tumor cells and strongly and diffusely positive in the lymphoma-like tumor cells.
Discussion
Anorectal malignant melanoma is a rare disease of elderly people that shows considerable histologic variability. Misdiagnosis is not uncommon, particularly in amelanotic cases with unusual morphologic features that can be mistaken for lymphoma, carcinoma, and/or sarcoma. [2] [3] [4] Immunohistochemical stains for the diagnosis of cutaneous malignant melanoma have become available and are now widely used. 3, 4 Anti-S-100 protein is the most common screening immunohistochemical stain used in the diagnosis of malignant melanoma and is highly sensitive for melanocytic differentiation. A protein thought to affect intracellular trafficking of calcium, S-100 protein is present in many tissue types, including nerve sheath tumors and gliomas, neuroendocrine cells, melanocytic proliferations, some histiocytic proliferations, Langerhans cells, and, rarely, poorly differentiated carcinomas. 25 Given the lack of specificity, it is used primarily as a screening tool. In this case series, it was present in all cases.
HMB-45 and antibodies to MelanA (also known as MART-1) are the 2 most common "melanocyte-specific" stains used in the diagnosis of malignant melanoma. These 2 monoclonal antibodies are specific for the inner membrane proteins present on premelanosomes and, thus, are seen almost exclusively in cells that show some form of melanocytic differentiation. These stains are highly specific for melanocytic neoplasms but also may be seen in other tumors with melanocytic differentiation (eg, angiomyolipomas, lymphangioleiomyomatosis, clear cell myomelanocytic tumors). An exception to this rule is the labeling of MelanA/MART-1 in adrenocortical tumors and some sex-cord stromal tumors of the gonads, which do not seem to have differentiation along melanocytic lines. However, although these stains are highly specific for melanocytes, sensitivity is decreased compared with S-100 protein. 25 HMB-45 commonly is reported to be positive in 90% to 100% of cutaneous melanomas, and staining for MelanA shows a similar distribution. 4, 25 However, MelanA and HMB-45 commonly fail to stain desmoplastic malignant melanomas with spindle cell morphologic features, leading to a common diagnostic pitfall in dermatopathology. In this series, HMB-45 reactive antigen and MelanA were present in the majority of cases (94% and 93%, respectively). It is interesting that both were positive in the melanomas with spindle cell morphologic features but negative in 1 of the 2 cases with pure lymphoma-like morphologic features (case 9).
Antityrosinase antibodies also are considered melanocyte-specific and target the tyrosinase enzyme needed early in the cascade to create melanin pigment. These antibodies are less widely used but are considered highly specific and sensitive for melanocytic neoplasms with sufficient maturation. 25 However, similar to HMB-45 and anti-MelanA, these antibodies are uncommonly present in cutaneous spindle cell-type malignant melanomas. 3 In this series, antityrosinase was present in the majority of cases (86%). In contrast with HMB-45 and MelanA, it was positive in case 9 but was negative in case 3, which was the only other tumor with pure lymphoma-like morphologic features (which showed focal positivity with HMB-45 and for MelanA).
Vimentin was included as a control in this case series because it typically is uniformly present in malignant melanoma. Staining for vimentin in this series was present in the majority of cases (93%). The lack of staining for vimentin in case 16 is unclear because the stroma and vasculature permeating the tumor tissue showed adequate staining as an internal control. All other stains except keratin were strongly and diffusely positive in case 16, including KIT and tyrosinase. All cases in this series were negative for pancytokeratin. While this is the expected result, it is important to remember that up to 10% of melanomas can show expression of a keratin or epithelial marker (most commonly CAM 5.2 and epithelial membrane antigen). 3, 4, 25, 26 It is particularly relevant in this series because case 12 originally was misdiagnosed as a poorly differentiated rectal carcinoma. At initial diagnosis, the tumor was positive for epithelial membrane antigen, while mucicarmine, synaptophysin, chromogranin, and pancytokeratin were negative, and melanocytic markers were not performed. The original biopsy was amelanotic, but the subsequent resection showed moderate pigmentation. Repeated immunohistochemical staining on the original biopsy specimen and the resection specimen demonstrated staining for S-100 protein and staining with HMB-45. An additional diagnostic pitfall is the report of anorectal malignant melanomas showing carcinoembryonic antigen positivity. This seems to be a particular problem with polyclonal carcinoembryonic antigen antibodies and is seen less commonly with monoclonal preparations. 11 KIT is a transmembrane tyrosine kinase receptor that functions in the development and proliferation of melanocytes. Small studies have shown that loss of c-kit gene expression is correlated with progression of cutaneous malignant melanoma, with decreased expression of KIT protein in metastatic lesions. [17] [18] [19] [20] In this series, KIT expression was present in 75% of cases, of which 10 showed intermediate to diffuse staining. Loss of KIT was present in the 2 cases with pure lymphoma-like tumor morphologic features, while all cases without lymphoma-like morphologic features showed at least focal positivity. It is interesting that spindle cell morphologic features were not correlated with KIT loss, and a tumor with pure spindle cell morphologic features could be mistaken for a gastrointestinal stromal tumor of the rectum.
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❚Image 2❚ Junctional change present at the edge of invasive tumor (H&E, ×200).
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❚Image 3❚ Immunohistochemical staining demonstrating strong staining with HMB-45 (A, ×200) and for KIT (B, ×200).
A B C ❚Image 4❚ (Case 4) Biphasic tumor showing differential staining between epithelioid and lymphoma-like regions (A, H&E, ×200; B, S-100 protein, ×200; C, KIT, ×200).
staining patterns similar to other cell types. This is in contrast with the dropped expression of many melanocytic markers in cutaneous spindle cell malignant melanomas. The loss of KIT expression does not seem to be associated with faster progression or decreased survival. The overall prognosis of the patients in this case series was similar to that noted in other reports of anal malignant melanoma, 1,21-24 with a mean survival from diagnosis of 32.3 months. The only 2 long-term survivors, cases 3 and 6, eventually died of disease, and their tumors did not show distinctive morphologic or immunohistochemical features. The 2 cases in which the primary lesion was identified on screening colonoscopy were not significantly smaller than those that were symptomatic, and metastasis developed in both at diagnosis or after definitive treatment.
Anorectal malignant melanoma is a highly lethal disease of elderly people, which often manifests with advanced disease. There can be considerable histologic variability, and the use of a panel of immunohistochemical stains, including S-100 protein, MelanA, HMB-45, tyrosinase, and a pankeratin, is helpful to the diagnosis. Expression of KIT can be present in anorectal malignant melanomas, and, when present in spindle cell tumors, can lead to confusion with gastrointestinal stromal tumors.
